8-K//Current report
Eiger BioPharmaceuticals, Inc. 8-K
Accession 0001193125-24-212606
CIK 0001305253operating
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 6:30 AM ET
Size
149.0 KB
Accession
0001193125-24-212606
Documents
- 8-Kd889209d8k.htmPrimary
8-K
- EX-101.SCHeigrq-20240903.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABeigrq-20240903_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREeigrq-20240903_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-24-212606-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd889209d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 6:30 AM ET
- Size
- 149.0 KB